Safety Alerts & Recalls
What does this mean?
This recall for Methylin Chewable Tablets 2.5 mg, 5 mg and 10 mg was issued at a warehouse and pharmacy level only. The FDA and the manufacturer have determined that any recalled product that may have been dispensed to patients does not pose a significant health risk. If you or someone you care for takes Methylin Chewable Tablets 2.5 mg, 5 mg, or 10 mg and are concerned, you should speak to your doctor.
Mallinckrodt Inc. Recalls Several Lots of Methylin Chewable Tablets (methylphenidate HCl) 2.5 mg, 5 mg and 10 mg
Mallinckrodt Inc. is recalling several lots of Methylin Chewable Tablets (methylphenidate HCl) 2.5 mg, 5 mg, and 10 mg. The following lot numbers have been recalled because stability testing indicated these lots may expire earlier than the expiration date stated: Methylin Chewable Tablets 2.5 mg – Lot number AMT21102A
Methylin Chewable Tablets 5 mg – Lot numbers AMT51101A and AMT51102A
Methylin Chewable Tablets 10 mg – Lot numbers AMTIOI lOlA and AMTIOII02A
Methylin contains the active ingredient methylphenidate and is commonly used in the treatment of attention deficit disorder (ADD). This recall alert only applies to the select lots of Methylin Chewable Tablets 2.5 mg, 5 mg, and 10 mg. No other methylphenidate products were involved in this recall.
To view the FDA notice about this recall, please visit: more information here